Complex Coronary Interventions | Tuesday Session

Tuesday, February 28, 2023

9:00 AM – 1:00 PM ET

Program Director(s)

Rasha Al-Lamee, MA, MD, PhD

Interventional Cardiology Consultant
Imperial College London
London, England, United Kingdom

Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)
Maurice Buchbinder, MD, FSCAI

Medical Director
Foundation for Cardiovascular Medicine
San Diego, California, United States

No relationships to disclose
Lowell Satler, MD, FSCAI

Director of the Cardiac Cath Lab
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure information not submitted.

Disclosure(s):

Rasha Al-Lamee, MA, MD, PhD: Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

Lowell F. Satler, MD, FSCAI: No financial relationships to disclose